Table: Rohto -2020/21 parent results
May 12 (Reuters)-
Rohto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 101.01 106.48
(-5.1 pct) (+2.0 pct)
Operating 13.02 13.26
(-1.9 pct) (+1.9 pct)
Recurring 12.56 14.37
(-12.6 pct) (-5.4 pct)
Net 8.92 6.98
(+27.8 pct) (+44.9 pct)
EPS 78.20 yen 61.19 yen
EPS Diluted 77.97 yen 61.00 yen
Ann Div 28.00 yen 26.00 yen 30.00 yen
-Q2 Div 13.00 yen 13.00 yen 15.00 yen
-Q4 Div 15.00 yen 13.00 yen 15.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T